Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

01 Communique Reports Results for Second Quarter Fiscal 2013

TORONTO, June 5, 2013 /CNW/ - 01 Communique Laboratory Inc. (ONE:TSX) today announced results for its second quarter 2013 which ended April 30, 2013. The loss for the second quarter 2013 was $1,169,030 compared to $615,312 in 2012 an increase of $553,718 due primarily to the costs incurred for the LogMeIn Inc. ("LogMeIn") patent lawsuit of $688,000. Excluding non-cash expenses for stock-based compensation and depreciation, and the costs of the LogMeIn lawsuit the loss for the second quarter 2013 becomes $378,701 compared to $395,040 in 2012. The Company completed the quarter with $3,803,212 of cash and cash equivalents.

"During the second quarter our patent litigation against LogMeIn concluded with a jury verdict finding our patent was valid but that LogMeIn did not infringe," said Andrew Cheung, President and CEO for 01 Communique. "We disagree with the jury finding of non-infringement and are seeking to have their finding overturned by the district court where the case was heard. We are waiting for the judge to render his decision. Should our efforts in this regard be unsuccessful then we plan to appeal to the United States Court of Appeals for the Federal Circuit. We believe in the merits of our appeal."

"Going forward, our plan is to continue development of our suite of products as we strive to maintain our competitiveness," said Andrew Cheung. "We will also continue to vigorously defend our intellectual property rights as we have been doing against LogMeIn and Citrix Systems Inc. ("Citrix"). We have reduced our operating expenses to conserve our cash resources and at the same time allow us to carry on with these two objectives."

Citrix Litigation Update - On May 8, 2013 a hearing took place in front of the United States Patent and Trademark Office's ("USPTO") Patent Trial and Appeal Board ("PTAB") in respect of the Citrix appeal of the results of the inter partes re-examination of our United States patent number 6,928,479 ("'479 Patent") which Citrix had requested. The hearing is the last step in the appeal process at the PTAB and we are now waiting for them to render their written report, which we expect to receive within the next few months. We are confident in the merits of our case and believe the PTAB will uphold the validity of the '479 Patent just as the jury did in the LogMeIn lawsuit and the USPTO patent examiner did in the Right of Appeal Notice ("RAN") and the Examiner's Report filed last year as part of the appeal process.

Financial Highlights -

    --  Operating expenses for the second quarter 2013 were $1,369,785
        compared to $722,733 in 2012 an increase of $647,032.
    --  Cash operating expenses which exclude stock-based compensation
        and depreciation were $1,267,436 for 2013 compared to $502,461
        in 2012 an increase of $764,975. Excluding patent enforcement
        and re-examination costs, the cash operating expenses for the
        second quarter 2013 were $449,043 compared to 2012 of $502,461
        a reduction of $53,418.
    --  Cash operating expenses have been further reduced and net of
        patent enforcement and re-examination costs are expected to be
        approximately $400,000 for the third quarter 2013.

The Toronto Stock Exchange has not reviewed and does not accept responsibility 
for the adequacy or the accuracy of this release.

About 01 Communique
Established in 1992, 01 Communique Laboratory Inc. (TSX: ONE) offers a suite 
of remote access services designed for small-medium sized business, mobile 
professionals and IT service providers. 01's software as a service offerings 
are deployed on-demand and include functionality enabling on-line meetings, 
remote computing and IT support. 01's suite of products includes its remote 
access offering I'm InTouch (, its online meeting offering 
( and its remote support offering I'm OnCall 
( ) products are protected in the U.S.A. by its patents 
#6928479 / #6938076 / #8234701 and in  Canada by its patent #2309398 and 
Japan by its patent #4,875,094. For more information, visit or 
call (905) 795-888 or (800) 668-2185 (North America only).

Cautionary Note Regarding Forward-looking Statements.
Certain statements in this news release may constitute "forward-looking" 
statements which involve known and unknown risks, uncertainties and other 
factors which may cause the actual results, performance or achievements of the 
company, or industry results, to be materially different from any future 
results, performance or achievements expressed or implied by such 
forward-looking statements. When used in this news release, such statements 
use such words as "may", "will", "expect", "believe", "plan", "intend", "are 
confident" and other similar terminology. These statements reflect current 
expectations regarding future events and operating performance and speak only 
as of the date of this news release.  Forward-looking statements involve 
significant risks and uncertainties, should not be read as guarantees of 
future performance or results, and will not necessarily be accurate 
indications of whether or not such results will be achieved.  A number of 
factors could cause actual results to differ materially from the results 
discussed in the forward-looking statements, including, but not limited to, 
the factors discussed under "Risk Factors" in the company's Annual Information 
Form filed on SEDAR. Although the forward-looking statements contained in this 
news release are based upon what management of the Company believes are 
reasonable assumptions, the company cannot assure investors that actual 
results will be consistent with these forward looking statements. These 
forward-looking statements are made as of the date of this news release, and 
the company assumes no obligation to update or revise them to reflect new 
events or circumstances.
                                       01 Communique Laboratory Inc.
                                      SELECTED FINANCIAL INFORMATION
                               Consolidated Statements of Financial Position
                                         30-Apr-13                            31-Oct-12



Cash and $ 3,803,212 $ 4,547,375 cash equivalents

Accounts receivable 283,836 282,981

Prepaid expenses and 94,590 35,676 other assets

                                         4,181,638                            4,866,032

Property and                                                                           
equipment                                   19,143                               17,261
                                    $    4,200,781                         $  4,883,293



Accounts $ 1,384,597 $ 407,770 payable and accrued liabilities

Deferred revenue 27,159 34,596

                                         1,411,756                              442,366


Share capital 39,997,277 39,566,407

Contributed 4,036,066 3,752,710 surplus

Agent options 111,780 248,400

                                      (41,356,098)                         (39,126,590)
                                         2,789,025                            4,440,927
                                    $    4,200,781                         $  4,883,293
                                                  01 Communique Laboratory Inc.
                                                 SELECTED FINANCIAL INFORMATION
                                 Consolidated Statements of Operations and Comprehensive Income
                                   For the 3 and 6 month periods ended April 30, 2013 and 2012
               for the 3 months ending                         for the 6 months ending
                            30-Apr-13              30-Apr-12               30-Apr-13              30-Apr-12

Revenue                    $  191,964             $  103,284              $  366,439             $  171,372

Cost of                                                                                                 223
revenue                           -                       82                     -  
                              191,964                103,202                 366,439                171,149


Selling,                      343,236                474,932                 776,015              1,007,714
general and

Patent                        818,393                                      1,397,100                       
litigation and                                           -                                              -  

Research and                  208,136                247,802                 441,692                493,476

Interest                                                                    (18,860)                      
                              (8,771)                (4,219)                                        (8,894)
                            1,360,994                718,514               2,595,947              1,492,296

Loss for the              (1,169,030)              (615,312)             (2,229,508)            (1,321,147)
period and

Loss per                                                                                                   
common share

Basic                     $   (0.018)            $   (0.010)             $   (0.034)            $   (0.022)

Diluted                   $   (0.018)            $   (0.010)             $   (0.034)            $   (0.022)

average number
of common

Basic                      65,012,745             60,216,489              65,019,357             60,163,712

Diluted                    65,012,745             60,216,489              65,019,357             60,163,712
                                                            01 Communique Laboratory Inc.
                                                            SELECTED FINANCIAL INFORMATION
                                                        Consolidated Statements of Cash Flows
                                             For the 3 and 6 month periods ended April 30, 2013 and 2012
                                                   three months ending                      six months                  

30-Apr-13 30-Apr-12 30-Apr-13 30-Apr-12

Cash provided by (used in):

Operating activities:

Loss for the period $ (1,169,030) $ (615,312) $ $ (1,321,147)


  Adjustments to reconcile the loss for                                                                                 

the period to net cash flows from operating                                                                             

     Depreciation                                                1,829                                                  

2,206 3,903 5,561

Stock-based compensation

100,500 218,066 283,356 500,708

Interest income

(8,771) (4,218) (18,860) (8,893)

Change in non-cash working capital

564,366 (227,484) 909,621 (305,531)


(626,742) (1,051,488) (1,129,302)

Interest income received

8,771 4,218 18,860 8,893


(622,524) (1,032,628) (1,120,409)


Financing activities:                                                                                                   
    Issue of common shares                                                                                              

189,750 100,000 294,250 100,000

Investing activities:

Purchase of capital assets

(452) (649) (5,785) (790)

Increase (decrease) in cash (313,037)

(523,173) (744,163) (1,021,199)

Cash and cash equivalents, beginning of period

4,116,249 2,623,391 4,547,375 3,121,417

Cash and cash equivalents, end of period $ 3,803,212 $ 2,100,218 $ $ 2,100,218


INVESTOR CONTACT: Brian Stringer Chief Financial Officer 01 Communique (905) 795-2888 x204

SOURCE: 01 Communique Laboratory Inc.

To view this news release in HTML formatting, please use the following URL:

CO: 01 Communique Laboratory Inc. ST: Ontario NI: CPR ELE SOF ERN

-0- Jun/05/2013 21:00 GMT

Sponsored Links
Sponsored Links